Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Santarus Stock Pops To 8-Year High On Drug Approval
Santarus Stock Pops To 8-Year High On Drug Approval
Santarus Stock Pops To 8-Year High On Drug Approval
Submitted by
admin
on January 15, 2013 - 11:43am
Source:
Investors.com
News Tags:
FDA
ulcerative colitis
Santarus
Uceris
Headline:
Santarus Stock Pops To 8-Year High On Drug Approval
Do Not Allow Advertisers to Use My Personal information
